Naomi Y. Ko, MD, MPH

Associate Professor, Medicine

Naomi Ko
FGH building, 1st floor, 820 Harrison Avenue


Breast Cancer
Cancer Disparities
Health Equity

Dr. Ko is an Associate Professor of Medicine at Chobanian and Avedisian School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women’s Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Center of Excellence in Women’s Health, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • Johns Hopkins University School of Medicine, MD
  • Johns Hopkins University School of Public Health, MPH
  • Harvard University, AM
  • Barnard College, BA


  • Published on 12/16/2022

    Beaulieu-Jones BR, Fefferman A, Woods AP, Shewmaker G, Zhang T, Roh DS, Sachs TE, Merrill A, Ko NY, Cassidy MR. Impact of Race, Ethnicity, Primary Language and Insurance on Reconstruction after Mastectomy for Patients with Breast Cancer at an Urban, Academic Safety-Net Hospital. J Am Coll Surg. 2022 Dec 16. PMID: 36524735.

    Read at: PubMed
  • Published on 12/8/2022

    Patel JV, Hughes DM, Ko NY. OPTIMAL Breast Cancer Care: Effect of an Outpatient Pharmacy Team to Improve Management and Adherence to Oral Cancer Treatment. JCO Oncol Pract. 2022 Dec 08; OP2200135. PMID: 36480784.

    Read at: PubMed
  • Published on 10/11/2022

    Freedman RA, Ko NY, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL. Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Res Treat. 2022 Dec; 196(3):623-633. PMID: 36220997.

    Read at: PubMed
  • Published on 10/1/2022

    Choi JJ, Fikre T, Fischman A, Buck AK, Ko NY. The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients. Oncologist. 2022 Oct 01; 27(10):832-838. PMID: 36124631.

    Read at: PubMed
  • Published on 9/10/2022

    Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220. PMID: 36087190.

    Read at: PubMed
  • Published on 7/5/2022

    Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B. Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 Jul 05; 27(7):518-524. PMID: 35443045.

    Read at: PubMed
  • Published on 7/1/2022

    Battaglia TA, Gunn CM, Bak SM, Flacks J, Nelson KP, Wang N, Ko NY, Morton SJ. Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study. Cancer. 2022 Jul 01; 128 Suppl 13:2623-2635. PMID: 35699610.

    Read at: PubMed
  • Published on 4/23/2022

    Huang HC, Smart MH, Zolekar A, Deng H, Hubbard CC, Hoskins KF, Ko NY, Guadamuz JS, Calip GS. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity. Breast Cancer Res Treat. 2022 Jun; 193(3):707-716. PMID: 35460499.

    Read at: PubMed
  • Published on 4/14/2022

    Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast. 2022 Aug; 64:19-28. PMID: 35468476.

    Read at: PubMed
  • Published on 2/28/2022

    Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes Control. 2022 May; 33(5):793-799. PMID: 35226243.

    Read at: PubMed

View 52 more publications: View full profile at BUMC

View all profiles